Consequently, frequent HER3 expression in HER2-dependent breast cancer subtype does not seem to inversely associate with NRDP1 expression, but the result needs to be confirmed in a larger sample cohort because of relatively low NRDP1 expression observed in the current study. The gene discussed is ERBB3; the disease is breast cancer.